Bml Capital Management, LLC Portfolio Holdings

Bml Capital Management, LLC

  • $161 Billion
  • Q4 2024

Bml Capital Management, LLC has filed its 13F form on February 06, 2025 for Q4 2024 where it was disclosed a total value porftolio of $161 Billion distributed in 25 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Aclaris Therapeutics, Inc. with a value of $35.3B, Ishares Trishares 0 3 Mnth Tre with a value of $26.1B, Atea Pharmaceuticals, Inc. with a value of $25.5B, Adverum Biotechnologies Inc with a value of $10.6B, and An2 Therapeutics, Inc. with a value of $7.93B.

Examining the 13F form we can see an decrease of $8.98B in the current position value, from $170B to 161B.

Bml Capital Management, LLC is based out at Zionsville, IN

Below you can find more details about Bml Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $161 Billion
Healthcare: $113 Billion
ETFs: $26.1 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 25
  • Current Value $161 Billion
  • Prior Value $170 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 06, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 4 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Bml Capital Management, LLC Portfolio

Follow Bml Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bml Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email